{"id":"https://openalex.org/W7225147170","doi":"https://doi.org/10.1016/j.parkreldis.2026.108782","title":"A decade of patient-focused innovation in the delivery of apomorphine infusion to improve the treatment experience for people with Parkinson\u2019s","display_name":"A decade of patient-focused innovation in the delivery of apomorphine infusion to improve the treatment experience for people with Parkinson\u2019s","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225147170","doi":"https://doi.org/10.1016/j.parkreldis.2026.108782"},"language":"en","primary_location":{"id":"doi:10.1016/j.parkreldis.2026.108782","doi":"https://doi.org/10.1016/j.parkreldis.2026.108782","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.parkreldis.2026.108782","pdf_url":null,"source":{"id":"https://openalex.org/S147691530","display_name":"Parkinsonism & Related Disorders","issn_l":"1353-8020","issn":["1353-8020","1873-5126"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Parkinsonism & Related Disorders","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014040995","display_name":"Bharat Amlani","orcid":"https://orcid.org/0000-0002-7384-7857","observed_orcids":["https://orcid.org/0000-0002-7384-7857"]},"institutions":[{"id":"https://openalex.org/I4405269016","display_name":"Britannia Pharmaceuticals Ltd (United Kingdom)","ror":"https://ror.org/02tg6rx53","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405269016"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"B. Amlani","raw_affiliation_strings":["Britannia Pharmaceuticals Limited, Green Park, Reading, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Britannia Pharmaceuticals Limited, Green Park, Reading, UK","institution_ids":["https://openalex.org/I4405269016"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160496519","display_name":"V. Correa-Gallego","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405269016","display_name":"Britannia Pharmaceuticals Ltd (United Kingdom)","ror":"https://ror.org/02tg6rx53","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405269016"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"V. Correa-Gallego","raw_affiliation_strings":["Britannia Pharmaceuticals Limited, Green Park, Reading, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Britannia Pharmaceuticals Limited, Green Park, Reading, UK","institution_ids":["https://openalex.org/I4405269016"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405269016"],"apc_list":{"value":3460,"currency":"USD","value_usd":3460},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.83474135,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"152","issue":null,"first_page":"108782","last_page":"108782"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9473000168800354,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9473000168800354,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14189","display_name":"Intravenous Infusion Technology and Safety","score":0.020099999383091927,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.007300000172108412,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apomorphine","display_name":"apomorphine","score":0.9639999866485596},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9330000281333923}],"concepts":[{"id":"https://openalex.org/C2777525119","wikidata":"https://www.wikidata.org/wiki/Q269111","display_name":"Apomorphine","level":4,"score":0.9639000296592712},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7713000178337097},{"id":"https://openalex.org/C35785553","wikidata":"https://www.wikidata.org/wiki/Q756720","display_name":"Ambulatory","level":2,"score":0.5547999739646912},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5203999876976013},{"id":"https://openalex.org/C2776390293","wikidata":"https://www.wikidata.org/wiki/Q2035485","display_name":"Subcutaneous injection","level":2,"score":0.4169999957084656},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.38989999890327454},{"id":"https://openalex.org/C2778258207","wikidata":"https://www.wikidata.org/wiki/Q600203","display_name":"Dopamine agonist","level":4,"score":0.3562000095844269},{"id":"https://openalex.org/C3018112808","wikidata":"https://www.wikidata.org/wiki/Q640448","display_name":"Continuous infusion","level":2,"score":0.35269999504089355},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3073999881744385},{"id":"https://openalex.org/C19720800","wikidata":"https://www.wikidata.org/wiki/Q7722","display_name":"Morning","level":2,"score":0.3037000000476837},{"id":"https://openalex.org/C2776187130","wikidata":"https://www.wikidata.org/wiki/Q201035","display_name":"Infusion pump","level":2,"score":0.27549999952316284},{"id":"https://openalex.org/C2779352459","wikidata":"https://www.wikidata.org/wiki/Q6031679","display_name":"Infusion therapy","level":2,"score":0.259799987077713}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.parkreldis.2026.108782","doi":"https://doi.org/10.1016/j.parkreldis.2026.108782","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.parkreldis.2026.108782","pdf_url":null,"source":{"id":"https://openalex.org/S147691530","display_name":"Parkinsonism & Related Disorders","issn_l":"1353-8020","issn":["1353-8020","1873-5126"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Parkinsonism & Related Disorders","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7225196326","https://openalex.org/W2516036621","https://openalex.org/W3081801825","https://openalex.org/W2166534380","https://openalex.org/W2997062070","https://openalex.org/W2071294003","https://openalex.org/W2102005555","https://openalex.org/W2182216675","https://openalex.org/W3090133425","https://openalex.org/W4386356818"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-11-04T00:00:00"}